Dr. Annalisa Jenkins, Executive Vice President, Head of Global Drug Development and Medical for Merck Serono, Honored by Gilda’s Club New York City
ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, has announced that Dr. Annalisa Jenkins, Executive Vice President, Head of Global Drug Development and Medical for Merck Serono, has been recognized by Gilda’s Club New York City for her advocacy work on behalf of people living with cancer.